CMS Cites OM1 Led Outcomes Standardization Effort In Treatment Resistant Depression Memo
Read the decision memo: https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=292
Showing 86-90 of 92 :
Applying AI for personalized treatment decisions and lowering costs in orthopedics
Becker’s Spine Review | Written by Richard Gliklich, MD, CEO, OM1 | November 26, 2018 In healthcare, results really matter Understanding why certain treatments and procedures work better on some patients and not so well on others is the key to delivering more personalized care and ultimately achieving better results for all stakeholders in the care process.[…]
New Harmonized Outcome Measures for Atrial Fibrillation Published in HeartRhythm
November 15, 2018 —OM1, a leading health outcomes and technology company, today announced the publication of new harmonized outcome measures for atrial fibrillation (AF) in HeartRhythm. OM1’s Richard Gliklich and Michelle Leavy collaborated on the development of the measures and co-authored the publication. The work was funded by the Agency for Healthcare Research and Quality (AHRQ) through[…]
OM1 Named to CIOReview Top 100 Big Data Providers 2017
BOSTON, August 22, 2017 — OM1 has been recognized by CIOReview Magazine as one of the top 100 most promising big data solution providers in 2017. OM1 was nominated and ultimately selected following CIOReview’s annual comprehensive review process. CIOReview’s editorial team analyzed approximately 1,000 companies that provide big data solutions and are at the forefront[…]
Becker’s Spine, Orthopedic, and Spine Conference – Chicago
On June 22-23, we were at the annual Becker’s Spine, Ortho and Pain conference in Chicago and talking about how we’re demonstrating that measured, precise and pre-emptive care generates real ROI. Interested in learning more or furthering our discussions? Contact us at info@om1.com.